Definitive Analysis
Definitive Analysis
Financial Statements
Periods / Units
Fundamentals
Valuations
Miscellaneous
Analysis Mode
Full Access
See Pricing Start Trial

Profarma Distribuidora de Produtos Farmacêuticos S.A.

Intrinsic Value Analysis (Discounted Cash Flow)Industry: Medical - DistributionSector: Healthcare

Fair Value Summary

Current Price$8.74
5Y Range93.67 – 233.83
5Y Selected163.75
(-) Safety Margin46.45%
5Y Buy Price$92.96
Upside (to Buy Price)963.64%
10Y Range123.84 – 306.46
10Y Selected215.15
(-) Safety Margin46.45%
10Y Buy Price$122.14
Upside (to Buy Price)1,297.48%

Company Predictability & Safety

MetricValue
Revenue R2 (5Y)0.9928
Revenue R2 (10Y)0.9131
Net Income R2 (5Y)0.6627
Net Income R2 (10Y)0.7530
EBITDA R2 (5Y)0.8298
EBITDA R2 (10Y)0.8136
FCF R2 (5Y)0.9004
FCF R2 (10Y)0.6777
Safety Score0.5677

DA 10-Year Projection

Metric2025202620272028202920302031203220332034
% Growth14.76%13.56%12.37%11.17%9.98%8.78%7.59%6.39%5.20%4.00%
Revenue11,652.3213,232.9214,869.7216,531.1918,180.6519,777.3421,277.8022,637.7023,813.8624,766.41
EBITDA561.09637.20716.01796.02875.44952.331,024.581,090.061,146.691,192.56
D&A-173.23-196.72-221.06-245.76-270.28-294.01-316.32-336.54-354.02-368.18
EBIT387.86440.47494.96550.26605.16658.31708.26753.52792.67824.38
Pro forma Taxes0.000.000.000.000.000.000.000.000.000.00
NOPAT387.86440.47494.96550.26605.16658.31708.26753.52792.67824.38
Capital Expenditures-49.21-55.88-62.80-69.81-76.78-83.52-89.86-95.60-100.57-104.59
NWC Investment-167.63-176.79-183.08-185.84-184.49-178.59-167.83-152.11-131.55-106.54
(+) D&A173.23196.72221.06245.76270.28294.01316.32336.54354.02368.18
Free Cash Flow344.25404.52470.14540.36614.17690.21766.89842.35914.57981.42
Diluted Shares Outstanding122,611,000.00122,611,000.00122,611,000.00122,611,000.00122,611,000.00122,611,000.00122,611,000.00122,611,000.00122,611,000.00122,611,000.00

Discounting Periods

MetricDec-25Dec-26Dec-27Dec-28Dec-29Dec-30Dec-31Dec-32Dec-33Dec-34
Period Start9/30/251/1/261/1/271/1/281/1/291/1/301/1/311/1/321/1/331/1/34
Period End12/31/2512/31/2612/31/2712/31/2812/31/2912/31/3012/31/3112/31/3212/31/3312/31/34
Mid-Point11/15/257/2/267/2/277/1/287/2/297/2/307/2/317/1/327/2/337/2/34
Time (t)0.100.461.462.463.464.465.466.467.468.46
Valuation Date1/16/26

Base Case Projected Flows

WACC: 6.50%Terminal Growth: 3.07%
Metric2025202620272028202920302031203220332034TV (5y)TV (10y)
Discount Factor0.990.970.910.860.800.760.710.670.630.59
PV UFCF342.09392.98428.86462.85493.97521.27543.85560.92571.86576.23
Raw: 18,477.12
14,400.69
Raw: 29,526.02
16,798.62

Base Case Valuation

5-Year Horizon10-Year Horizon
UFCFUFCF
Enterprise Value16,521.4421,693.49
(-) Net Debt206.09206.09
Equity Value16,315.3421,487.39
(/) Shares Out122.61122.61
Fair Value$133.07$175.25
(-) Safety Margin46.45%46.45%
Buy Price$71.26$93.85
Current Price$8.74$8.74
Upside (to Buy Price)715.30%973.75%

Conservative Projected Flows

WACC: 7.50%Terminal Growth: 2.57%
Metric2025202620272028202920302031203220332034TV (5y)TV (10y)
Discount Factor0.990.970.900.840.780.720.670.630.580.54
PV UFCF341.77391.29423.05452.33478.25499.99516.79528.06533.35532.42
Raw: 12,788.37
9,604.85
Raw: 20,435.52
10,692.67

Conservative Valuation

5-Year Horizon10-Year Horizon
UFCFUFCF
Enterprise Value11,691.5415,389.95
(-) Net Debt206.09206.09
Equity Value11,485.4515,183.86
(/) Shares Out122.61122.61
Fair Value$93.67$123.84
(-) Safety Margin46.45%46.45%
Buy Price$50.16$66.32
Current Price$8.74$8.74
Upside (to Buy Price)473.94%658.75%

Aggressive Projected Flows

WACC: 5.50%Terminal Growth: 3.57%
Metric2025202620272028202920302031203220332034TV (5y)TV (10y)
Discount Factor0.990.980.920.880.830.790.750.710.670.64
PV UFCF342.41394.68434.81473.72510.36543.67572.60596.17613.56624.10
Raw: 33,026.88
26,720.33
Raw: 52,776.19
32,675.21

Aggressive Valuation

5-Year Horizon10-Year Horizon
UFCFUFCF
Enterprise Value28,876.3137,781.28
(-) Net Debt206.09206.09
Equity Value28,670.2237,575.19
(/) Shares Out122.61122.61
Fair Value$233.83$306.46
(-) Safety Margin46.45%46.45%
Buy Price$125.22$164.11
Current Price$8.74$8.74
Upside (to Buy Price)1,332.68%1,777.67%

Reverse DCF: Market Implied Growth

Current Price$8.74
WACC Used6.5%
IMPLIED REVENUE GROWTH54.59%
Metric2027202820292030203120322033203420352036
Implied Revenue17,435.3526,953.2841,667.0364,412.9999,575.95153,934.30237,966.79367,872.49568,693.51879,142.41
Constant Implied Growth54.59%54.59%54.59%54.59%54.59%54.59%54.59%54.59%54.59%54.59%
Implied Free Cash Flow1.742.704.176.449.9615.3923.8036.7956.8787.91
Discount Factor0.950.860.800.760.710.670.630.590.550.52
Present Value of Implied FCF1.652.313.354.867.0610.2514.8821.6031.3545.51

Rolling Historical DCF (Backtest)

Valuation based on actual realized growth.
YearValuation DateActual PriceRealized Growth (5Y)Calculated Fair ValueValuation Delta
20192019-12-31$5.3115.34%$17.98238.70%
20182018-12-31$3.2815.35%$-20.99-740.03%
20172017-12-31$7.1314.07%$-46.84-756.92%
20162016-12-31$6.390.41%$-41.94-756.36%
20152015-12-31$3.77-12.27%$0.58-84.67%
20142014-12-31$6.69-20.10%$-1.23-118.36%
20132013-12-31$13.77-18.47%$-30.46-321.19%
20122012-12-31$10.55-11.84%$-5.31-150.32%
20112011-12-31$9.84-7.73%$0.44-95.55%
20102010-12-31$11.07-4.62%$9.24-16.51%
20092009-12-31$11.462.07%$27.96144.00%
20082008-12-31$3.558.18%$-3.85-208.42%
20072007-12-31$23.939.22%$-104.06-534.83%
20062006-12-31$19.7210.44%$-56.29-385.46%
20052005-12-31$16.9812.39%$-18.51-209.01%
20042004-12-31$16.986.86%$-30.00-276.67%

Monte Carlo Simulation (1,000 Iterations)

Mean Fair Value
$196.88
Median
$174.64
10th Percentile
$125.33
90th Percentile
$287.72

Fair Value Distribution

$42.77 - $115.80
65
$115.80 - $188.83
548
$188.83 - $261.86
255
$261.86 - $334.89
72
$334.89 - $407.92
29
$407.92 - $480.95
12
$480.95 - $553.98
8
$553.98 - $627.01
3
$627.01 - $700.04
3
$700.04 - $773.07
2
$773.07 - $846.10
0
$846.10 - $919.13
0
$919.13 - $992.16
1
$992.16 - $1,065.19
0
$1,065.19 - $1,138.22
0
$1,138.22 - $1,211.25
1
$1,211.25 - $1,284.28
0
$1,284.28 - $1,357.31
0
$1,357.31 - $1,430.34
0
$1,430.34 - $1,503.37
1